Amann F, Hefner G, Cremer-Schaeffer P, Gründer G, Häuser W, Hart XM, Petzke F, Zernig G, Havemann-Reinecke U. Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and Nabilone. Pharmacopsychiatry. 2026 Jun 10. [Epub ahead of print]
Hart XM, Gründer G, Hiemke C, Adamovic I, Amann F, Baumann P, Bergemann N, Brandt C, Clement HW, Conca A, Deckert J, Dietmaier O, Eckermann G, Egberts K, Endres K, Erlacher N, Fekete S, Ferrea S, Florio V, Gerlach M, Haen E, Hahn M, Havemann-Reinecke U, Hefner G, Jost WH, Kuzin M, Laux G, Leucht S, Maniscalco I, Menke A, Messer T, Moessner R, Müller DJ, Müller T, Paulzen M, Petri H, Pfeifer P, Pfuhlmann B, Riederer P, Roll SC, Scherf-Clavel M, Schwarz M, Steimer W, Stingl JC, Toto S, Ulrich S, Zernig G, Zurek G, Unterecker S, Schoretsanitis G. Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects. Pharmacopsychiatry. 2026 Jul 2. [Epub ahead of print]